Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Composition CJC-1295 (Without DAC): 5 mg Ipamorelin: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models Assessment of assay development, including chromatographic separation of co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
Gross, V
Psychiatry 69 , 314324 (2012)
Injectable GHK-Cu has demonstrated systemic effects in animal models -- lung fibrosis protection, connective tissue remodeling, neuroprotection -- but translating those findings to human subcutaneous injection protocols remains speculative
US$ 21.34
US$ 21.79
US$ 20.58
US$ 22.31
US$ 26.47